Free Trial
CVE:DBV

Doubleview Capital (DBV) Stock Price, News & Analysis

C$0.08 +0.01 (+7.14%)
As of 05/7/2020

About Doubleview Capital Stock (CVE:DBV)

Key Stats

Today's Range
C$0.07
C$0.08
50-Day Range
C$0.08
C$0.08
52-Week Range
C$0.04
C$0.14
Volume
86,000 shs
Average Volume
122,095 shs
Market Capitalization
C$8.62 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive DBV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Doubleview Capital and its competitors with MarketBeat's FREE daily newsletter.

DBV Stock News Headlines

Kepler Capital Sticks to Their Buy Rating for DBV Technologies (0QAJ)
DBV Technologies (0QAJ) Receives a Buy from Kepler Capital
10 Cheap Stocks Ready to Explode
Remember when Nvidia was trading at $60? Yeah, me too. Painful, right? While early investors turned every $10,000 into $100,000+, most of us watched from the sidelines, thinking we'd already missed the boat. Here's the thing though... The AI revolution isn't over. It's just getting started.
Kepler Capital Sticks to Its Buy Rating for DBV Technologies (0QAJ)
See More Headlines

DBV Stock Analysis - Frequently Asked Questions

Doubleview Capital's stock was trading at C$0.08 at the start of the year. Since then, DBV stock has increased by 0.0% and is now trading at C$0.08.

Shares of DBV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Doubleview Capital investors own include Tetra Bio-Pharma (TBPMF) and Cona Resources (CONA).

Industry, Sector and Symbol

Stock Exchange
CVE
Industry
Industrial Metals & Minerals
Sub-Industry
Pharmaceutical Products
Current Symbol
CVE:DBV
CIK
N/A
Fax
N/A
Employees
80
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.81
Quick Ratio
2.81

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
C$0.00 per share
Price / Cash Flow
17.50
Book Value
C$0.05 per share
Price / Book
1.53

Miscellaneous

Outstanding Shares
114,871,000
Free Float
N/A
Market Cap
C$8.62 million
Optionable
Not Optionable
Beta
N/A
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (CVE:DBV) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners